Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Amy Wheless"'
Autor:
Eric D. Routh, Amanda E. D. Van Swearingen, Maria J. Sambade, Steven Vensko, Marni B. McClure, Mark G. Woodcock, Shengjie Chai, Luz A. Cuaboy, Amy Wheless, Amy Garrett, Lisa A. Carey, Alan P. Hoyle, Joel S. Parker, Benjamin G. Vincent, Carey K. Anders
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundTriple negative breast cancer (TNBC) is an aggressive variant of breast cancer that lacks the expression of estrogen and progesterone receptors (ER and PR) and HER2. Nearly 50% of patients with advanced TNBC will develop brain metastases (B
Externí odkaz:
https://doaj.org/article/15f0d0e7c2c44235bb8dc96191eb0af9
Clinical subtype, treatment response, and survival in De Novo and recurrent metastatic breast cancer
Autor:
Danielle M. File, Tomas Pascual, Allison M. Deal, Amy Wheless, Charles M. Perou, E. Claire Dees, Lisa A. Carey
Publikováno v:
Breast Cancer Res Treat
PURPOSE: This study evaluated whether patients with de novo metastatic breast cancer (MBC) have superior outcomes compared to those with recurrent MBC in a contemporary treatment era and examined factors related to outcome differentials. METHODS: Usi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0904e738c23958060951c5992fdac8aa
https://doi.org/10.1007/s10549-022-06700-6
https://doi.org/10.1007/s10549-022-06700-6
Publikováno v:
Cancer Research. 82:P1-17
Background. Loss of estrogen receptor (ER) and/or progesterone receptor (PR) expression between primary breast tumors and metastases occurs in one-fourth of patients. Loss of hormone receptor (HR) expression is associated with inferior clinical outco
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2605b927c0afc1276a1c4e0d21091ebf
https://doi.org/10.1158/1538-7445.sabcs21-p1-17-05
https://doi.org/10.1158/1538-7445.sabcs21-p1-17-05
Autor:
Susana, Garcia-Recio, Toshinori, Hinoue, Gregory L, Wheeler, Benjamin J, Kelly, Ana C, Garrido-Castro, Tomas, Pascual, Aguirre A, De Cubas, Youli, Xia, Brooke M, Felsheim, Marni B, McClure, Andrei, Rajkovic, Ezgi, Karaesmen, Markia A, Smith, Cheng, Fan, Paula I Gonzalez, Ericsson, Melinda E, Sanders, Chad J, Creighton, Jay, Bowen, Kristen, Leraas, Robyn T, Burns, Sara, Coppens, Amy, Wheless, Salma, Rezk, Amy L, Garrett, Joel S, Parker, Kelly K, Foy, Hui, Shen, Ben H, Park, Ian, Krop, Carey, Anders, Julie, Gastier-Foster, Mothaffar F, Rimawi, Rita, Nanda, Nancy U, Lin, Claudine, Isaacs, P Kelly, Marcom, Anna Maria, Storniolo, Fergus J, Couch, Uma, Chandran, Michael, Davis, Jonathan, Silverstein, Alexander, Ropelewski, Minetta C, Liu, Susan G, Hilsenbeck, Larry, Norton, Andrea L, Richardson, W Fraser, Symmans, Antonio C, Wolff, Nancy E, Davidson, Lisa A, Carey, Adrian V, Lee, Justin M, Balko, Katherine A, Hoadley, Peter W, Laird, Elaine R, Mardis, Tari A, King
Publikováno v:
Nature cancer.
The AURORA US Metastasis Project was established with the goal to identify molecular features associated with metastasis. We assayed 55 females with metastatic breast cancer (51 primary cancers and 102 metastases) by RNA sequencing, tumor/germline DN
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::93f1fb740e8c81c0546ac85b735dd468
https://pubmed.ncbi.nlm.nih.gov/36585450
https://pubmed.ncbi.nlm.nih.gov/36585450
Clinical Subtype, Treatment Response, and Survival in De Novo and Recurrent Metastatic Breast Cancer
Autor:
Danielle File, Tomas Pascual, Allison Deal, Amy Wheless, Charles Perou, E. Claire Dees, Lisa Anne Carey
Purpose. This study evaluated whether patients with de novo metastatic breast cancer (MBC) have superior outcomes compared to those with recurrent MBC in a contemporary treatment era and examined factors related to outcome differentials.Methods. Usin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8647f0b7b3e4780a3419fb6dda94afd0
https://doi.org/10.21203/rs.3.rs-1479039/v1
https://doi.org/10.21203/rs.3.rs-1479039/v1
Autor:
Amy Wheless, Michael Lorentsen, Hyman B. Muss, Kirsten A. Nyrop, Addison Tucker Brenizer, Shlomit S. Shachar, Emily Damone, Grant W Williams, Allison Mary Deal, Lisa A. Carey
Publikováno v:
Cancer. 127:922-930
BACKGROUND This study investigates obesity and comorbidity in Black and White women with early breast cancer (stages I-III) and their potential impact on treatment decisions for patients with hormone receptor-positive (HR+)/human epidermal growth fac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc44d5c9364c5353e2cb1efc1e7c6efa
https://doi.org/10.1002/cncr.33288
https://doi.org/10.1002/cncr.33288
Autor:
Jordan T. Lee, Hyman B. Muss, Lisa A. Carey, Allison M. Deal, Shlomit S. Shachar, Amy Wheless, Ji Hye Park, Erin A. O’Hare, Seul Ki Choi, Kirsten A. Nyrop
Publikováno v:
Breast Cancer Research and Treatment. 179:709-720
Weight gain after breast cancer (BC) diagnosis is a well-known phenomenon; however, it is not a universal phenomenon and identification of patients at highest risk for weight gain is needed. This study investigates weight trajectories in early BC pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23f994b726913850b2c2cb218e9ec23f
https://doi.org/10.1007/s10549-019-05501-8
https://doi.org/10.1007/s10549-019-05501-8
Autor:
Amanda Van Swearingen, Eric Routh, Maria Sambade, Steven Vensko, Marni McClure, Mark Woodcock, Shengjie Chai, Luz Cuaboy, Amy Wheless, Amy Garrett, Lisa Carey, Alan Hoyle, Joel Parker, Benjamin Vincent, Carey Anders
Publikováno v:
Neuro-Oncology Advances. 4:i2-i2
BACKGROUND Triple negative breast cancer (TNBC) lacks expression of hormone receptors (estrogen and progesterone receptors, ER and PR) and HER2. Almost 50% of patients with metastatic TNBC will develop brain metastases (BrM), often with concurrent pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::96a6205e6d8f346edd8924aa3fd850c2
https://doi.org/10.1093/noajnl/vdac078.006
https://doi.org/10.1093/noajnl/vdac078.006
Autor:
Kirsten A. Nyrop, Amy Wheless, Jordan T. Lee, Hyman B. Muss, Shlomit S. Shachar, Seul Ki Choi, Lisa A. Carey, Allison M. Deal
Publikováno v:
Breast Cancer Research and Treatment. 167:235-248
This study investigates weight trajectories in pre- versus postmenopausal breast cancer (BC) survivors diagnosed with hormone receptor-positive tumors, with a specific focus on discerning menopausal status and type of endocrine treatment (ET) as risk
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::31f4d3dd15fd9868f8adc736f29d8e2c
https://doi.org/10.1007/s10549-017-4501-4
https://doi.org/10.1007/s10549-017-4501-4
Autor:
Allison M. Deal, Kirsten A. Nyrop, Amy Wheless, Jordan T. Lee, Samara Ann Dixon, Shlomit S. Shachar, Seul Ki Choi, Lisa A. Carey, Hyman B. Muss
Publikováno v:
Breast Cancer Research and Treatment. 162:375-388
Obesity and weight gain after breast cancer (BC) diagnosis can affect cancer outcomes. This study explores the question of weight change during the first 2 years of endocrine treatment (ET) to identify the independent effects of BC diagnosis and trea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bfb12c9f1b336a6a959db155e0d790fe
https://doi.org/10.1007/s10549-017-4106-y
https://doi.org/10.1007/s10549-017-4106-y